FDA approves

TRENTON, N.J. | FDA approves new pill to reduce pain from endometriosi

TRENTON, N.J. — U.S. regulators have approved a new treatment for pain caused by endometriosis. The common condition involves abnormal tissue growth from the uterus that can cause pain and infertility. Drugmaker Abbvie said Tuesday that the Food and Drug Administration approved its drug, Orilissa (oh-RAH’-liss-ah), for pain during menstruation and at other times. The … Continue reading TRENTON, N.J. | FDA approves new pill to reduce pain from endometriosi

TRENTON, N.J. | FDA approves 1st nonopioid drug to ease withdrawal symptoms

TRENTON, N.J. (AP) — Federal regulators have approved the first nonopioid treatment to ease withdrawal symptoms from quitting addictive opioids. The U.S. Food and Drug Administration expedited approval of Lucemyra (luc-eh-MEER’-eh) to help combat the U.S. opioid epidemic. The tablet was approved Wednesday to treat adults for up to two weeks for common withdrawal symptoms … Continue reading TRENTON, N.J. | FDA approves 1st nonopioid drug to ease withdrawal symptoms